PrescottG.WoodruffMD
Pulmonology • San Francisco, CACritical Care Medicine, Pleural Disease
Professor, Medicine, UCSF School of Medicine
Dr. Woodruff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
505 Parnassus Ave
San Francisco, CA 94143Phone+1 415-476-9456Fax+1 415-502-7814
Education & Training
University of California (San Francisco)/FresnoFellowship, Pulmonary Disease and Critical Care Medicine, 2002
Massachusetts General HospitalResidency, Internal Medicine, 1993 - 1996
Columbia University Vagelos College of Physicians and SurgeonsClass of 1993
Certifications & Licensure
CA State Medical License 1998 - 2025
MA State Medical License 1996 - 1999- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2012
Clinical Trials
- Zileuton to Treat Adults With Chronic Obstructive Pulmonary Disease (The LEUKO Study) Start of enrollment: 2007 Mar 01
- Chitinases and Transforming Growth Factor Beta (TGFB) in Human Asthma Start of enrollment: 2010 Feb 01
- Role of microRNAs in T Cell-Driven Inflammation in Asthma Start of enrollment: 2012 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 32 citationsBronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung Function.MeiLan K Han, Wen Ye, Di Wang, Emily White, Mehrdad Arjomandi
The New England Journal of Medicine. 2022-09-29 - 162 citationsAt the Root: Defining and Halting Progression of Early Chronic Obstructive Pulmonary Disease.Fernando J. Martinez, MeiLan K. Han, James Allinson, R. Graham Barr, Richard C. Boucher
American Journal of Respiratory and Critical Care Medicine. 2018-06-15 - 73 citationsAirway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohortGiorgia Radicioni, Agathe Ceppe, Amina A. Ford, Neil E. Alexis, R. Graham Barr
The Lancet. Respiratory Medicine. 2021-05-28
Press Mentions
PRE-PROOF Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation PRE-PROOFJanuary 4th, 2023- About 20-40% of Adults with COPD Symptoms, but Who Have Not Been Diagnosed with COPD, Use These Types of Long-Term InhalersSeptember 5th, 2022
- Bronchodilators Do Not Improve Smoking-Related Respiratory Symptoms in People Without COPDSeptember 4th, 2022
- Join now to see all
Grant Support
- Spiriomics Clinical CenterNational Heart, Lung, And Blood Institute2011
- Role Of TH2 And Non-Th2 Inflammation In Airway Smooth Muscle Remodeling In AsthmaNational Heart, Lung, And Blood Institute2009–2011
- Molecular Phenotyping Of AsthmaNational Heart, Lung, And Blood Institute2008–2011
- Spiromics Clinical CenterNational Heart, Lung, And Blood Institute2010
- Spiriomics Clinical CenterNational Heart, Lung, And Blood Institute2010
- Spiromics Clinical CenterDivision Of Lung Diseases2009
- Mechanisms Of Smooth Muscle Hyperreactivity On AsthmaNational Center For Research Resources2002–2006
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
